SCHEMBL3451102

SCHEMBL3451102

Nc1nc(O)cc(-c2ccccc2)n1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.73
ADORA1 P30542 3/20 0.73
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
LMNA P02545 2/20 0.64
MAPT P10636 2/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
MAPK10 P53779 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
KDM4E B2RXH2 2/20 0.61
HSP90AA1 P07900 2/20 0.61
HSP90AB1 P08238 1/20 0.61
CYP1A1 P04798 1/20 0.58
CYP1B1 Q16678 1/20 0.58
ALDH1A1 P00352 3/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904514 0.85 ADORA2A (1.00) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL716998 0.84 ADORA2A (0.50) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL19417246 0.81 ADORA2A (0.91) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL3450486 0.81 MEN1 (0.47) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL18931741 0.81 KDM4E (0.58) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL3451384 0.81 KDM4E (0.60) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL8995844 0.80 MAP4K4 (0.52) ADORA2AADORA1KDM4EHSP90AA1HSP90AB1
SCHEMBL20019135 0.80 ADORA2A (0.80) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL3451123 0.79 MEN1 (0.52) ADORA2AADORA1MEN1KMT2ALMNA
SCHEMBL3307656 0.79 MEN1 (0.68) ADORA2AADORA1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116103008-B Strippable polyurethane hot melt adhesive based on reactive extrusion and synthesis method thereof 郑州大学 2025-03-21 CN claimed
CN-116376507-A Ureido pyrimidinone modified polyethyleneimine adhesive and synthetic method thereof 郑州大学 2023-07-04 CN claimed
CN-114716961-B Self-complementary quadruple hydrogen bond supermolecule hot melt adhesive and synthesis method thereof 郑州大学 2023-06-23 CN claimed
CN-116103008-A Strippable polyurethane hot melt adhesive based on reactive extrusion and synthesis method thereof 郑州大学 2023-05-12 CN claimed
CN-114716961-A Self-complementary quadruple hydrogen bond supramolecular hot melt adhesive and synthesis method thereof 郑州大学 2022-07-08 CN claimed
CN-108067191-A For the reactor assembly of orthophosphates in Adsorption waste water 北京益清源环保科技有限公司 2018-05-25 CN claimed
CN-108059205-A For the up-flow adsorptive reactor of orthophosphates in Adsorption waste water 北京益清源环保科技有限公司 2018-05-22 CN claimed
CN-107930577-A There is the modified bentonite adsorbent of absorption property to the orthophosphates in water body 北京益清源环保科技有限公司 2018-04-20 CN claimed
EP-1796673-A2 NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM Reddy US Therapeutics, Inc. (US) 2007-06-20 EP claimed
US-20060084645-A1 Novel pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2006-04-20 US claimed
WO-2006034473-A2 NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM REDDY US THERAPEUTICS, INC. (US) 2006-03-30 WO claimed
CN-116103008-B Strippable polyurethane hot melt adhesive based on reactive extrusion and synthesis method thereof 郑州大学 2025-03-21 CN disclosed
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS, SAN DIEGO 2023-11-23 US disclosed
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
CN-116376507-A Ureido pyrimidinone modified polyethyleneimine adhesive and synthetic method thereof 郑州大学 2023-07-04 CN disclosed
US-5002951-A 2-amino-5-halo-4-pyrimidinol for bactericides and antiprotozoa agent THE UPJOHN COMPANY (US) 1991-03-26 US disclosed
US-4665077-A IMMUNOREGULATORY AGENTS THE UPJOHN COMPANY (US) 1987-05-12 US disclosed
US-4619933-A 6-aryl pyrimidines for treating aplastic anemia THE UPJOHN COMPANY (US) 1986-10-28 US disclosed
US-4543248-A Method for immunoregulation with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-09-24 US disclosed
US-4507302-A Method for treating arthritis with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084645-A1 Novel pyrimidine compounds, process for their preparation and compositions containing them UMPS, DPYD, TYMS ADORA2A 1490/4885ADORA1 2067/4885MEN1 4470/4885
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1G, SCNN1B ADORA2A 1622/4885ADORA1 1287/4885MEN1 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.